Seguir
Christina Decatur
Christina Decatur
Dirección de correo verificada de med.miami.edu
Título
Citado por
Citado por
Año
PRAME as an independent biomarker for metastasis in uveal melanoma
MG Field, CL Decatur, S Kurtenbach, G Gezgin, PA Van Der Velden, ...
Clinical cancer research 22 (5), 1234-1242, 2016
2132016
Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes
CL Decatur, E Ong, N Garg, H Anbunathan, AM Bowcock, MG Field, ...
JAMA ophthalmology 134 (7), 728-733, 2016
1902016
Single-cell analysis reveals new evolutionary complexity in uveal melanoma
MA Durante, DA Rodriguez, S Kurtenbach, JN Kuznetsov, MI Sanchez, ...
Nature communications 11 (1), 1-10, 2020
1792020
L-DOPA Is an Endogenous Ligand for OA1
VM Lopez, CL Decatur, WD Stamer, RM Lynch, BS McKay
PLoS biology 6 (9), e236, 2008
1732008
Punctuated evolution of canonical genomic aberrations in uveal melanoma
MG Field, MA Durante, H Anbunathan, LZ Cai, CL Decatur, AM Bowcock, ...
Nature communications 9 (1), 1-10, 2018
1282018
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
MG Field, MA Durante, CL Decatur, B Tarlan, KM Oelschlager, JF Stone, ...
Oncotarget 7 (37), 59209, 2016
992016
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis
LL Cavalcante, ML Cavalcante, TG Murray, MM Vigoda, Y Piña, ...
Clinical ophthalmology (Auckland, NZ) 4, 519, 2010
422010
2016
H Field, MA Durante, CL Decatur, B Tarlan, KM Oelschlager, JF Stone
Science without Numbers, 1980
391980
BAP1 loss is associated with DNA methylomic repatterning in highly aggressive class 2 uveal melanomas
MG Field, JN Kuznetsov, PL Bussies, LZ Cai, KA Alawa, CL Decatur, ...
Clinical cancer research 25 (18), 5663-5673, 2019
342019
2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β ActivationInhibition of …
K Kovács, C Decatur, M Toro, DG Pham, H Liu, Y Jing, TG Murray, ...
Molecular cancer therapeutics 15 (2), 264-275, 2016
322016
Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma
L Cai, M Paez-Escamilla, SD Walter, B Tarlan, CL Decatur, BM Perez, ...
American journal of ophthalmology 195, 154-160, 2018
302018
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
SK Houston, NV Shah, C Decatur, M Lonngi, W Feuer, AM Markoe, ...
Clinical ophthalmology (Auckland, NZ) 7, 193, 2013
202013
Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice
NV Shah, DG Pham, TG Murray, C Decatur, E Hernandez, NN Shah, ...
Journal of Ophthalmology 2014, 2014
192014
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LHBETATAG retinal tumors
Y Pina, C Decatur, TG Murray, SK Houston, M Lopez-Cavalcante, ...
Investigative ophthalmology & visual science 53 (2), 996-1002, 2012
192012
Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBetaTag retinal tumors
Y Piña, C Decatur, TG Murray, SK Houston, D Gologorsky, M Cavalcante, ...
Clinical Ophthalmology (Auckland, NZ) 5, 337, 2011
162011
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-D-glucose on molecular genomics expression in LHBETATAG retinal tumors
Y Piña, SK Houston, TG Murray, T Koru-Sengul, C Decatur, WK Scott, ...
Clinical ophthalmology (Auckland, NZ) 6, 817, 2012
122012
Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
M Lonngi, SK Houston, TG Murray, RA Sisk, CL Decatur, M Cavalcante, ...
Clinical Ophthalmology (Auckland, NZ) 7, 427, 2013
112013
Genomic evolution of uveal melanoma arising in ocular melanocytosis
MA Durante, MG Field, MI Sanchez, KR Covington, CL Decatur, ...
Molecular Case Studies 5 (4), a004051, 2019
82019
Intraocular metastasis in unilateral multifocal uveal melanoma without melanocytosis or germline BAP1 mutations
MA Durante, SD Walter, M Paez-Escamilla, J Tokarev, CL Decatur, ...
JAMA ophthalmology 137 (12), 1434-1439, 2019
52019
Combined glycolytic inhibition and anti-vascular treatment in retinoblastoma: Novel strategy for tumor control avoids chemotherapy
TG Murray, S Houston, C Decatur, Y Pina, T Lampidis
Cancer Research 72 (8_Supplement), 4642-4642, 2012
42012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20